Comparative effectiveness of 5 treatment strategies for early-stage non-small cell lung cancer in the elderly
about
Considerations for observational research using large data sets in radiation oncologyTreatment of early stage non-small cell lung cancer: surgery or stereotactic ablative radiotherapy?Cost-effectiveness of stereotactic radiation, sublobar resection, and lobectomy for early non-small cell lung cancers in older adultsStereotactic radiotherapy for early lung cancer: Evidence-based approach and future directionsEarly lung cancer diagnosis by biosensors.Intensity modulated radiotherapy for stage III non-small cell lung cancer in the United States: predictors of use and association with toxicities.Lobectomy, sublobar resection, and stereotactic ablative radiotherapy for early-stage non-small cell lung cancers in the elderly.Stereotactic body radiation therapy versus no treatment for early stage non-small cell lung cancer in medically inoperable elderly patients: A National Cancer Data Base analysis.Additional data in the debate on stage I non-small cell lung cancer: surgery versus stereotactic ablative radiotherapy.Stereotactic body radiotherapy for very elderly patients (age, greater than or equal to 85 years) with stage I non-small cell lung cancerOutcomes after stereotactic body radiotherapy for lung tumors, with emphasis on comparison of primary lung cancer and metastatic lung tumors.Measuring the population impact of introducing stereotactic ablative radiotherapy for stage I non-small cell lung cancer in CanadaCommunicating cancer treatment information using the Web: utilizing the patient's perspective in website developmentPulmonary artery invasion, high-dose radiation, and overall survival in patients with non-small cell lung cancerStereotactic ablative body radiation therapy for tumors in the lung in octogenarians: a retrospective single institution studyImpact of tumor attachment to the pleura measured by a pretreatment CT image on outcome of stage I NSCLC treated with stereotactic body radiotherapy.SBRT in operable early stage lung cancer patients.Pulmonologist involvement, stage-specific treatment, and survival in adults with non-small cell lung cancer and chronic obstructive pulmonary disease.Stereotactic radiotherapy for early stage non-small cell lung cancerOutcomes after Stereotactic Body Radiotherapy versus Limited Resection in Older Patients with Early-Stage Lung Cancer.Sublobar resection is associated with improved outcomes over radiotherapy in the management of high-risk elderly patients with Stage I non-small cell lung cancer: a systematic review and meta-analysis.The impact of tumor size on the association of the extent of lymph node resection and survival in clinical stage I non-small cell lung cancer.Stereotactic ablative radiotherapy: a potentially curable approach to early stage multiple primary lung cancer.Definition of stereotactic body radiotherapy: principles and practice for the treatment of stage I non-small cell lung cancer.Long-term outcomes of stereotactic body radiation therapy (SBRT) with fiducial tracking for inoperable stage I non-small cell lung cancer (NSCLC).A propensity-matched analysis of surgery and stereotactic body radiotherapy for early stage non-small cell lung cancer in the elderly.Robotic stereotactic body radiation therapy for elderly medically inoperable early-stage non-small cell lung cancer.Would screening for lung cancer benefit 75- to 84-year-old residents of the United States?Assessing Survival and Grading the Severity of Complications in Octogenarians Undergoing Pulmonary Lobectomy.New techniques for assessing response after hypofractionated radiotherapy for lung cancerGuideline for radiotherapy with curative intent in patients with early-stage medically inoperable non-small-cell lung cancer.Managing lung cancer in high-risk patients: what to consider.Stereotactic body radiotherapy in operable patients with stage I NSCLC: where is the evidence?Imaging features from pretreatment CT scans are associated with clinical outcomes in nonsmall-cell lung cancer patients treated with stereotactic body radiotherapy.Is surgery still the best management option for early stage NSCLC?Current challenges of lung cancer care in an aging population.Navigating the Challenges of Adjuvant Chemotherapy in Older Patients with Early-Stage Non-Small-Cell Lung Cancer.Treatment Burden of Medicare Beneficiaries With Stage I Non-Small-Cell Lung Cancer.Faculty of Radiation Oncology Position Paper on the use of Image-Guided Radiation Therapy.Undetected lymph node metastases in presumed early stage NSCLC SABR patients.
P2860
Q24289442-FCFB273B-515F-48DB-B8E6-B3FE299286DBQ26853124-096C13BF-C925-46FD-B459-9797CD7C4491Q27309908-3257A027-0C05-43A6-B849-34FE0EAFD79CQ28085744-1A3B518C-6CFA-4094-ADE8-A9AF881EDE75Q30449799-F11813A9-EE10-4F29-B190-41AF6129EADEQ30557710-C104F23A-4AA9-44F7-A8F9-75A7A769CC9EQ30640824-A7A4F323-BC51-4B8F-9738-AFDF33169C43Q30992150-8D39EA00-5142-46AD-9F08-55BEEEB0A81BQ30993385-7E0CC97E-F241-496D-9F91-1C668D0FCCC6Q33813917-FD81A035-A01A-46A7-8B06-586EAEC2E5EFQ33826696-3288007E-FF14-4D50-AAC0-C60CE6A37D50Q34005116-E2D4D13F-46C8-4523-A699-A9811BC3C088Q34740086-38B1EFDC-B47B-4EC9-815E-91484FE4A587Q34937327-F27F5406-237A-4ABD-A22A-B74E9DC76E56Q34995421-F8309D2C-907F-4D80-BC4B-796754DF7F4EQ35074232-71A2BE9D-B074-4DA9-B5B4-333AF329DDD8Q35200592-1EE292C5-5EF0-492C-AE99-45B1404369D3Q35565178-536EB237-677E-4052-82B8-3545142BB089Q35824255-14AAA04C-3EFA-4DD8-BD13-155D222F3F9FQ35880933-9C4828E0-1DB4-419C-859A-2FAAFBC99FA4Q36230657-A93EC40A-2D4A-46AC-A4A9-EDA78D69C1ADQ36494147-9972C9B4-01F5-4CC8-8631-FAF6DDA64E11Q37179433-2C14B0A5-35F8-4185-8A84-90B08FAD7E12Q37468265-A8F4CE33-7923-4065-AD99-D225E81EDF5DQ37491637-3050EA3B-4254-4DCC-BC77-2B5F600D420AQ37552170-DCAE2FFD-B677-441F-B8B7-3506B42C1392Q37566614-A1C0A776-33F0-4B1E-B8A8-222A80795FB8Q37622940-1E95C6F1-8412-4460-949B-E21EC47A7002Q37657305-18CEEBB4-CE94-4089-A85D-F0A6D2E9157DQ37670432-399F643C-BCBE-4DAA-ACD6-A73A2914D385Q37672027-B8D14E70-5FF6-414C-8608-451B8713BD9DQ38218238-1EA6A9E8-AB03-4CB0-AF85-67C5EB0D93FFQ38374340-8EDB102F-CBC8-4E0D-BE49-D8BD1E8BBB77Q38377300-B72D03D8-0C43-4194-8B16-40501CEA13B9Q38390136-EB71F3DC-A2D5-4DD3-9FAE-0CE51DC08B7AQ38608627-0E40F58B-29E3-4EF0-8C62-670F4373AEDCQ38749994-8BC10F09-F124-4B55-8219-5A6449F9A37EQ38780270-3B87241B-CE99-4A9B-BA9F-5E3916D665E3Q38819438-C9FA5CA2-306C-4DB8-9B44-42700A8C823EQ38859683-71D5245B-0BDD-4613-A6D2-B64BD017B2B9
P2860
Comparative effectiveness of 5 treatment strategies for early-stage non-small cell lung cancer in the elderly
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 September 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Comparative effectiveness of 5 ...... ell lung cancer in the elderly
@en
Comparative effectiveness of 5 ...... ll lung cancer in the elderly.
@nl
type
label
Comparative effectiveness of 5 ...... ell lung cancer in the elderly
@en
Comparative effectiveness of 5 ...... ll lung cancer in the elderly.
@nl
prefLabel
Comparative effectiveness of 5 ...... ell lung cancer in the elderly
@en
Comparative effectiveness of 5 ...... ll lung cancer in the elderly.
@nl
P2093
P2860
P1476
Comparative effectiveness of 5 ...... ell lung cancer in the elderly
@en
P2093
Daniel R Gomez
James W Welsh
Jing Jiang
Joe Y Chang
Shervin M Shirvani
Stephen Swisher
Thomas A Buchholz
P2860
P304
P356
10.1016/J.IJROBP.2012.07.2354
P407
P577
2012-09-11T00:00:00Z